Latest News

If you are wondering whether CarMax is finally priced like a bargain after its brutal slide, or if it is cheap for a reason, this article is for you. The stock has bounced 5.6% over the last week and 23.9% over the past month, but it is still down 49.3% year to date and 52.6% over the last year, a classic setup that attracts value hunters and risk takers alike. Recent headlines have focused on a tougher used car demand backdrop and shifting consumer sentiment, alongside ongoing questions...

BillionToOne (BLLN) has just put another big quarter on the board, with Q3 2025 revenue at about $62.8 million and Basic EPS of roughly -$0.20, as investors gauge how fast the top line can outrun still negative earnings. The company has seen revenue move from roughly $34.5 million in early 2024 to about $41.7 million later that year and then to $62.8 million in 2025, while Basic EPS shifted from about -$0.76 to -$1.30 and then to -$0.20 over the same stretch, setting up a story where rapid...

Recent updates show that Welltower Inc. reported very large normalized FFO growth and 14.5% same-store NOI growth, supported by stronger senior housing demand, occupancy gains, and active portfolio recycling through acquisitions and dispositions. A key insight is that this performance is underpinned by low leverage and ample liquidity, which give the healthcare REIT flexibility to pursue growth while managing macroeconomic and interest rate pressures. Next, we’ll examine how this strong...

Westpac Banking (ASX:WBC) is back in the spotlight after a rare governance protest vote, renewed pressure over its fossil fuel lending, and a recent eftpos outage that briefly disrupted thousands of customers. See our latest analysis for Westpac Banking. Despite this mix of governance tension, climate scrutiny and operational hiccups, Westpac’s A$38.26 share price still sits on a robust year to date share price return of 18.05 percent, underpinned by a strong 1 year total shareholder return...

In early December 2025, Citigroup Inc. redeemed all US$1.50 billions of its 4.000% Series W preferred stock and simultaneously created a new 6.625% Fixed Rate Reset Noncumulative Preferred Stock, Series HH, while continuing to issue and refinance a range of senior unsecured notes across currencies and maturities. These capital and funding moves, alongside new leadership appointments in Japan and South Korea and ongoing investor outreach, suggest Citi is actively reshaping its balance sheet...

Wondering if Sanofi is quietly turning into a bargain while the market is distracted? Let us unpack what the recent share price action really means for long term value focused investors. Despite a solid 29.7% gain over 5 years, the stock is down 12.3% year to date, with shorter term moves also in the red at 4.8% over 30 days and 3.5% over the last week, reminding investors that sentiment can shift faster than fundamentals. Recent headlines have centered on Sanofi’s strategic push deeper into...

Astellas Pharma (TSE:4503) is back in the spotlight as it prepares to unveil fresh XOSPATA clinical data at the American Society of Hematology meeting, a catalyst investors watch closely for clues on future leukemia revenue. See our latest analysis for Astellas Pharma. That backdrop of fresh XOSPATA data lands just as momentum has been rebuilding in the stock, with a 30 day share price return of 14.41 percent helping drive a 1 year total shareholder return of 36.03 percent and signalling...

Grab Holdings (GRAB) just wrapped a roadshow that refocused attention on its fintech engine, with management stressing accelerated loan growth and a realistic path to segment profitability next year, alongside fresh board changes supporting execution. See our latest analysis for Grab Holdings. Despite the fintech buzz and fresh board additions, Grab’s 1 month share price return of minus 12.2 percent shows momentum has cooled, even as its 3 year total shareholder return of 56.5 percent still...

Berkshire Hathaway (BRK.B) has quietly eased off its highs, with the stock down over the past week and month even as its year to date and 3 year returns remain comfortably positive. See our latest analysis for Berkshire Hathaway. That pullback comes after a strong run, with the latest share price at $490.43 and an 8.7% year to date share price return. The 5 year total shareholder return of 121.0% still underlines how powerful the long term compounding has been. If Berkshire’s slower momentum...

Teleflex (TFX) has quietly climbed about 16 % over the past month after a long stretch of weak returns, drawing fresh attention from investors who are wondering whether this rebound signals a genuine shift in sentiment. See our latest analysis for Teleflex. That 16.25% 1 month share price return stands in sharp contrast to Teleflex’s weak longer term total shareholder returns, with the 5 year total shareholder return down 66.55%. This suggests the latest move looks more like early momentum...

ABM Industries (ABM) has quietly outperformed the broader market over the past month, with the stock climbing about 9% even as its year to date and 1 year returns remain negative. See our latest analysis for ABM Industries. That recent 1 month share price return of 8.54% to about $45.90 stands in contrast to a weaker year to date share price return and a negative 1 year total shareholder return. This suggests near term momentum is improving even as the longer term picture remains more...

Earlier this week, Celldex Therapeutics announced it has begun a global Phase 3 EMBARQ trial of barzolvolimab in adults with cold urticaria and symptomatic dermographism who remain symptomatic despite H1 antihistamines or biologics, enrolling about 240 patients across 75 sites in 7 countries. This marks the second Phase 3 program for barzolvolimab and follows a prior placebo-controlled Phase 2 study where the drug achieved statistically significant improvements in provocation test responses...

In early December 2025, Capital Power announced it had signed an MOU with Apollo Funds to pursue U.S. merchant natural gas generation acquisitions, with up to US$3.00 billion of potential equity commitments and Capital Power operating the acquired assets and earning management and performance fees. Alongside this push into large-scale energy and data-center-linked power assets, Apollo is also extending its reach in private markets through areas such as sports ownership and retirement...

Aeva Technologies (AEVA) just landed a major win, being chosen as the exclusive LiDAR supplier for a top European automaker's global Level 3 vehicle platform. This development is sparking fresh attention on the stock and its long term revenue potential. See our latest analysis for Aeva Technologies. The market has been quick to respond, with a 12.78% 7 day share price return and year to date share price gains above 200 percent signaling that sentiment and growth expectations are clearly...

BellRing Brands (BRBR) just landed on the Zacks Rank 5 Strong Sell list after earnings estimates were cut by about 15% over the past two months, putting fresh pressure on expectations. See our latest analysis for BellRing Brands. Even with that downgrade, the stock has bounced hard in the very short term, with a 1 month share price return of 17.79%, but that comes after a steep year to date share price decline of 55.36%. Near term momentum looks more like a sharp rebound than a decisive trend...

Wondering if Ingevity at around $58.83 is still a smart buy or if the easy money has already been made? You are not alone; this stock has quietly been drawing fresh attention from value focused investors. After a tough few years, the share price has surged, up 12.6% over the last week, 18.8% over the past month, and 48.8% year to date, even though the 3 and 5 year returns are still down 15.5% and 19.7% respectively. Part of this turnaround story reflects shifting sentiment around specialty...

Amcor (AMCR) has quietly slipped about 3% over the past week and remains down roughly 12% this year, even as revenue and net income continue to grow. This sets up an interesting value debate. See our latest analysis for Amcor. At around $8.20, Amcor’s 1 year to date share price return of negative 12.3% and 1 year total shareholder return of negative 13.4% signal fading momentum, even as earnings growth nudges sentiment rather than transforms it. If you like the steady cash generation story...

Analyst Upgrade Tied to Insider Buying and Q3 Dividend Hold Arbor Realty Trust (ABR) just picked up an analyst upgrade after a wave of insider buying and a mixed Q3 update that still kept its quarterly dividend steady at 0.30 dollars per share. See our latest analysis for Arbor Realty Trust. The upgrade and insider buying come against a tougher backdrop, with the share price at 9.05 dollars and a steep year to date share price return of minus 34.33 percent. At the same time, the five year...

Engie (ENXTPA:ENGI) has quietly turned into one of the stronger performers in European utilities, with the stock up almost 19% over the past 3 months and more than 53% over the past year. See our latest analysis for Engie. That momentum has been building rather than fading, with a 90 day share price return of 18.6% and a five year total shareholder return of around 150%, signalling that investors are steadily repricing Engie’s growth and risk profile. If Engie’s run has you rethinking your...

In early December 2025, Deutsche Bank downgraded 3M from “Buy” to “Hold,” reflecting more cautious expectations for the company’s medium-term growth and aligning its outlook more closely with industrial peers. This shift in analyst sentiment comes even as 3M reports progress on its turnaround plan, including margin expansion and restructuring efforts such as the recent healthcare spin-off into Solventum. Against this backdrop of a more cautious Deutsche Bank rating, we’ll now examine how...

Earlier this week, Microsoft said it will invest US$17.50 billion in India and more than C$7.50 billion in Canada to build out cloud and AI infrastructure, while also confirming future price increases for Microsoft 365 commercial products. By pairing record-scale data center spending in key growth markets with higher monetization of its core productivity suite, Microsoft is tightening the link between its AI expansion and the subscription revenues that fund it. We’ll now examine how this...

Cloetta (OM:CLA B) just took a tangible step into the U.S. candy aisle, with subsidiary CandyKing opening a permanent Swedish Candy store in New York City, a move worth watching for long term brand building. See our latest analysis for Cloetta. That New York foothold comes on the back of strong momentum, with a roughly 13 percent 1 month share price return and a near 52 percent year to date share price gain. Long term total shareholder returns above 100 percent hint investors already see...

Equinix, Inc. recently announced that long-serving CFO Keith Taylor plans to retire in 2026 after 27 years, while the company was also named a Leader in the first IDC MarketScape: Worldwide Datacenter Services Sustainability 2025-2026 Vendor Assessment. This third‑party recognition highlights how Equinix’s early investments in renewable energy, green financing, and waste‑heat reuse are increasingly shaping its competitive positioning in datacenter services. We’ll now examine how this...

QuantumScape Corporation recently completed installation of key equipment for its higher-volume QSE-5 Eagle Line solid-state battery cell production in San Jose, and plans to shift its stock listing from the New York Stock Exchange to Nasdaq on December 23, 2025 while retaining the QS ticker. Together, the Eagle Line milestone and the upcoming Nasdaq move highlight QuantumScape’s push to transition from lab-scale innovation toward more scalable, technology-focused commercialization through...